Mar 2019 $5 M No. 5 $2 to $10 million 3
Corindus Vascular Robotics, Inc.: Raise no. 5, Mar 2019 × Investors in this round 3 investors had bought by the notice of Mar 21, 2019: 3 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 2 investors are named for Corindus Vascular Robotics, Inc. as a whole in other filings: see Investors below.
What the notice says
Amount sold $5 M of $5 M offered
Smallest investment taken no minimum stated
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice David W. Long · Executive Officer Douglas R. Teany · Executive Officer Mark J. Toland · Executive Officer, Director Campbell D. Rogers · Director Douglas L. Braunstein · Director James R. Tobin · Director Jeffrey C. Lightcap · Director Jeffrey G. Gold · Director Louis A. Cannon · Director Nathan R. Harrington · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by David W. Long, Chief Financial Officer. Source: SEC Form D, newest notice filed Mar 21, 2019. Read the notice at the SEC .
equity SEC Feb 2019 $15 M No. 4 $10 to $50 million 1
Corindus Vascular Robotics, Inc.: Raise no. 4, Feb 2019 × Investors in this round 1 investor had bought by the notice of Mar 11, 2019: 1 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 2 investors are named for Corindus Vascular Robotics, Inc. as a whole in other filings: see Investors below.
What the notice says
Amount sold $15 M of $15 M offered
Smallest investment taken no minimum stated
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice David W. Long · Executive Officer Douglas R. Teany · Executive Officer Mark J. Toland · Executive Officer, Director Campbell D. Rogers · Director Douglas L. Braunstein · Director James R. Tobin · Director Jeffrey C. Lightcap · Director Jeffrey G. Gold · Director Louis A. Cannon · Director Nathan R. Harrington · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by David W. Long, Chief Financial Officer. Source: SEC Form D, newest notice filed Mar 11, 2019. Read the notice at the SEC .
equity SEC Mar 2018 $25 M No. 3 $10 to $50 million 4
Corindus Vascular Robotics, Inc.: Raise no. 3, Mar 2018 × Investors in this round 4 investors had bought by the notice of Mar 28, 2018: 4 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 2 investors are named for Corindus Vascular Robotics, Inc. as a whole in other filings: see Investors below.
What the notice says
Amount sold $25 M of $25 M offered
Smallest investment taken no minimum stated
What was sold equity, options or other rights to buy securities Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice David W. Long · Executive Officer Mark J. Toland · Executive Officer, Director Campbell D. Rogers · Director Douglas L. Braunstein · Director James R. Tobin · Director Jeffrey C. Lightcap · Director Jeffrey G. Gold · Director Louis A. Cannon · Director Nthan R. Harrington · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by David W. Long, Chief Financial Officer. Source: SEC Form D, newest notice filed Mar 28, 2018. Read the notice at the SEC .
equity, options SEC Mar 2017 $45 M No. 2 $10 to $50 million 16
Corindus Vascular Robotics, Inc.: Raise no. 2, Mar 2017 × Investors in this round 16 investors had bought by the notice of Mar 29, 2017: 16 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 2 investors are named for Corindus Vascular Robotics, Inc. as a whole in other filings: see Investors below.
What the notice says
Amount sold $45 M of $45 M offered
Smallest investment taken no minimum stated
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice David W. Long · Executive Officer Mark J. Toland · Executive Officer, Director Stephen J. Lemaster · Executive Officer Campbell D. Rogers · Director Gerard G. Winkels · Director Jeffrey C. Lightcap · Director Jeffrey G. Gold · Director Louis A. Cannon · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by David W. Long, Chief Financial Officer. Source: SEC Form D, newest notice filed Mar 29, 2017. Read the notice at the SEC .
equity SEC Sep 2014 $27 M No. 1 $10 to $50 million 15
Corindus Vascular Robotics, Inc.: Raise no. 1, Sep 2014 × Investors in this round 15 investors had bought by the notice of Sep 23, 2014: 15 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 2 investors are named for Corindus Vascular Robotics, Inc. as a whole in other filings: see Investors below.
What the notice says
Amount sold $27 M of $27 M offered
Smallest investment taken $100,000
What was sold equity Exemption claimed Rule 506(c): may be advertised publicly; every buyer must be a verified accredited investor
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions $1,000,000
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Nevada People named in the notice David M Handler · Executive Officer, Director David W Long · Executive Officer David C White · Director Gerard C Winkels · Director Hillel C Bachrach · Director Jeffrey C Gold · Director Jeffrey C Lightcap · Director · Chairman Michael C Mashaal · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round Cowen and Company, LLC (CRD 7616) · New York, New York Sold in MA, NJ, NY, VA Stifel, Nicolaus & Company, Incorporated (CRD 0793) · San Francisco, California Sold in MA, NJ, NY, VA Signed by /s/ David M. Handler, Chief Executive Officer. Source: SEC Form D, newest notice filed Sep 23, 2014. Read the notice at the SEC .
equity SEC